Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
BD Completes Acquisition of HandyLab, Inc.
VisEn Launches New OsteoSense(R) 800 and VivoTag(R) 800 Fluorescence Molecular Imaging Agents
AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing
Spherix Announces Results of Annual Shareholders Meeting
MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.